(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
(b)(6) study report.Patient id: (b)(6).It was reported that on (b)(6) 2014, a 2.25x28mm xience prime stent was successfully implanted in the proximal circumflex (cx) coronary artery lesion and a 2.5x33mm xience prime stent was successfully implanted in the mid left anterior descending (lad) coronary artery lesion.In the year of 2017, the patient was hospitalized due to reported cardiac enlargement [cardiomegaly].Unspecified treatment was provided and the patient was discharged from the hospital.No additional information was provided.
|